Showing results (421-430 of 693) with videos related to

Sort By:
Pageof 70
Plos One|November 7, 2008
A miRNA signature of prion induced neurodegenerationReuben Saba, Chelsey D Goodman, Rhiannon L C H Huzarewich, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 1, 1993
Differential expression of lectin-binding sites defines mouse intestinal M-cellsM A Clark, M A Jepson, N L Simmons, et al.
Clinical and Laboratory Haematology|January 1, 1984
Haemorrhage associated with large abdominal aortic aneurysmsN A Booth, P W Buckler, A A Dawson, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|August 30, 2008
Use of an acellular regenerative tissue matrix in combination with vacuum-assisted closure therapy for treatment of a diabetic foot woundKyle L Randall, Branyan A Booth, Adrian J Miller, et al.
Musculoskeletal Care|December 19, 2007
Measuring fatigue among women with Sjögren's syndrome or rheumatoid arthritis: a comparison of the Profile of Fatigue (ProF) and the Multidimensional Fatigue Inventory (MFI)C E Goodchild, G J Treharne, D A Booth, et al.
Endocrinology|December 1, 1990
Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cellsB A Booth, R S Bar, M Boes, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 8, 2009
Chaotic advection in blood flowA B Schelin, Gy Károlyi, A P S de Moura, et al.
Bone Marrow Transplantation|July 1, 1994
Immunoreactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA-haploidentical transplantationD T Harris, M J Schumacher, J LoCascio, et al.
Scandinavian Journal of Rheumatology|May 6, 2004
Reactions to disability in patients with early versus established rheumatoid arthritisG J Treharne, A C Lyons, D A Booth, et al.
Psychopharmacology|January 1, 1986
Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123)R W Russell, C A Smith, R A Booth, et al.
Pageof 70